In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin

Table 5

Effect of storage on percentage residual content at refrigerated and room temperature.

Formulation code	Days interval	Initial percentage	Refrigerated temperature	Room temperature
NC2	7th day	96.78 ± 0.054	95.82 ± 0.023	93.21 ± 0.027
	14th day		94.43 ± 0.031	91.32 ± 0.034
	21st day		93.79 ± 0.017	88.29 ± 0.048
	28th day		90.69 ± 0.044	84.58 ± 0.031
	30th day		89.92 ± 0.051	82.39 ± 0.019